IDH2 and cyclic hematopoiesis: In coherence with observations on the risk that mutations in different genes pose for the progression of age-related CH into AML47,48, we found mutations of TP53 (significantly), IDH2 and several splicing factors (not significantly) overrepresented among tAML cases (Fig. 4b).